Credo Tech (CRDO) shares tanked despite upbeat Q3 earnings. Rosenblatt maintains Neutral with $125 PT. Needham reaffirms Buy with $220 PT. Latest Ratings for CRDO Date Firm Action From To Mar 2022 Cowen & Co. Maintains Outperform Mar 2022 Mizuho Maintains Buy Feb 2022 Roth Capital Initiates Coverage On Buy View More Analyst Ratings for CRDO View the Latest Analyst Ratings Importance Rank: 1 read more